A. Jeynes-Ellis

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial

T. Brümmendorf, J. Cortes, M. Deininger, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.

F. Albers, E. Israel, R. Panettieri, 2022, The New England journal of medicine.

Bosutinib (BOS) versus imatinib (IM) for newly diagnosed chronic myeloid leukemia (CML): Initial results from the BFORE trial.

T. Brümmendorf, J. Cortes, M. Deininger, 2017 .

A first-in-human phase I clinical trial of CXR1002 in patients (pts) with advanced cancer.

D. Bissett, C. Wolf, A. Barnett, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: 12-Month Patient-Reported Outcomes from the BFORE Trial

T. Brümmendorf, J. Cortes, M. Deininger, 2017 .